ALG3 and breast cancer: In the present study, our results demonstrated that ALG3 was remarkably upregulated in radioresistant breast cancer tissue, which predicted poor clinicopathological characteristics and OS, and poor local recurrence-free survival (LRFS) in breast cancer patients.